Am J Prev Med

Introduction:Many U.S. women continue to be screened annually for cervical cancer, despite current guidelines that recommend 3- or 5-year screening intervals depending on screening modality and patient age.Methods:Data from 2012 and 2015 web-based surveys of U.S. adults were analyzed in 2017 to investigate U.S. women\u2019s cervical cancer screening preferences. The study was limited to women aged 65 18 years without a hysterectomy or cervical cancer diagnosis (2012 n=1,380, 2015 n=1,339).Results:Women\u2019s preference for 3- or 5-year screening intervals doubled during the study period (2012: 31.2%, 2015: 64.2%, p<0.001). The most preferred screening options in 2015 were co-testing every 3 years with the Pap and human papillomavirus tests (34.0%) and annual Pap testing (30.4%)\u2014neither of which were recommended at that time or currently. Use of 3- and 5-year Pap testing intervals increased during the study period (2012: 6.9%, 2015: 12.9%, p<0.001), whereas annual Pap testing declined (2012: 48.5%, 2015: 35.6%, p